Business Description
Immunogen Inc
NAICS : 325412
SIC : 2834
ISIN : US45253H1014
Compare
Compare
Traded in other countries / regions
IMGN.USAIMU.Germany0A8K.UKIMGN.Mexico IPO Date
1989-12-31Description
Immunogen Inc is a clinical-stage biotechnology company from the United States. Its focus is antibody-drug conjugate, or ADC, technology, which uses an antibody that fixes on a target (its antigen) found on tumor cells to deliver a specific cancer-killing agent.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.71 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.17 | |||||
| Debt-to-EBITDA | -0.5 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 7.56 | |||||
| Beneish M-Score | 4.1 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -8.2 | |||||
| 3-Year EBITDA Growth Rate | -14.9 | |||||
| 3-Year EPS without NRI Growth Rate | -7.9 | |||||
| 3-Year FCF Growth Rate | -14 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 14.83 | |||||
| 9-Day RSI | 27.4 | |||||
| 14-Day RSI | 34.77 | |||||
| 6-1 Month Momentum % | 297.96 | |||||
| 12-1 Month Momentum % | 210.32 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.14 | |||||
| Quick Ratio | 7.11 | |||||
| Cash Ratio | 6.1 | |||||
| Days Inventory | 410.33 | |||||
| Days Sales Outstanding | 44.77 | |||||
| Days Payable | 5694.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -14.6 | |||||
| Shareholder Yield % | -0.31 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 99.1 | |||||
| Operating Margin % | -96.84 | |||||
| Net Margin % | -96.02 | |||||
| ROE % | -76.07 | |||||
| ROA % | -42.67 | |||||
| ROIC % | -243.73 | |||||
| ROC (Joel Greenblatt) % | -1146.67 | |||||
| ROCE % | -53.19 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 19.92 | |||||
| PB Ratio | 7.39 | |||||
| Price-to-Tangible-Book | 7.39 | |||||
| EV-to-EBIT | -18.26 | |||||
| EV-to-EBITDA | -18.44 | |||||
| EV-to-Forward-EBITDA | -17.19 | |||||
| EV-to-Revenue | 16.64 | |||||
| EV-to-Forward-Revenue | 7.59 | |||||
| EV-to-FCF | -12.87 | |||||
| Price-to-Median-PS-Value | 2 | |||||
| Price-to-Net-Current-Asset-Value | 8.13 | |||||
| Price-to-Net-Cash | 10.4 | |||||
| Earnings Yield (Greenblatt) % | -5.48 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:IMGN
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Immunogen Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 189.564 | ||
| EPS (TTM) ($) | -0.72 | ||
| Beta | 0.33 | ||
| Volatility % | 166.28 | ||
| 14-Day RSI | 34.77 | ||
| 14-Day ATR ($) | 0.639384 | ||
| 20-Day SMA ($) | 15.69525 | ||
| 12-1 Month Momentum % | 210.32 | ||
| 52-Week Range ($) | 3.605 - 20.69 | ||
| Shares Outstanding (Mil) | 248.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Immunogen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Immunogen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Immunogen Inc Frequently Asked Questions
What is Immunogen Inc(IMGN)'s stock price today?
The current price of IMGN is $14.56. The 52 week high of IMGN is $20.69 and 52 week low is $3.61.
When is next earnings date of Immunogen Inc(IMGN)?
The next earnings date of Immunogen Inc(IMGN) is 2023-11-03 Est..
Does Immunogen Inc(IMGN) pay dividends? If so, how much?
Immunogen Inc(IMGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers